Docetaxel Injection is a microtubule inhibitor indicated for: Breast Cancer (BC): single agent for locally advanced or metastatic BC after chemotherapy failure; and with doxorubicin and cyclophosphamide as adjuvant treatment of operable node-positive BC, Non-small Cell Lung Cancer (NSCLC): single agent for locally advanced or metastatic NSCLC after platinum therapy failure; and with cisplatin for unresectable…
From the U.S. FDA-approved label for Docetaxel. Full label: DailyMed.
Docetaxel Injection is a microtubule inhibitor indicated for: Breast Cancer (BC): single agent for locally advanced or metastatic BC after chemotherapy failure; and with doxorubicin and cyclophosphamide as adjuvant treatment of operable node-positive BC, Non-small Cell Lung Cancer (NSCLC): single agent for locally advanced or metastatic NSCLC after platinum therapy failure; and with cisplatin for unresectable, locally advanced or metastatic untreated NSCLC, Castration-Resistant Prostate Cancer (CRPC): with prednisone in metastatic castration-resistant prostate cancer, Gastric Adenocarcinoma (GC): with cisplatin and fluorouracil for untreated, advanced GC, including the gastroesophageal junction, Squamous Cell Carcinoma of the Head and Neck (SCCHN): with cisplatin and fluorouracil for induction treatment of locally advanced SCCHN 1.1 Breast Cancer Docetaxel Injection is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy. Docetaxel Injection in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer.
From the U.S. FDA-approved label for Docetaxel. Full label: DailyMed.
For all indications, toxicities may warrant dosage adjustments. Administer in a facility equipped to manage possible complications (e.g., anaphylaxis). Administer in a facility equipped to manage possible complications (e.g., anaphylaxis).
Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.
Docetaxel Injection is contraindicated in patients with: neutrophil counts of <1500 cells/mm 3., a history of severe hypersensitivity reactions to docetaxel or to other drugs formulated with polysorbate 80. Severe reactions, including anaphylaxis, have occurred., Hypersensitivity to docetaxel or polysorbate 80, Neutrophil counts of <1500 cells/mm 3
Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.
Second primary malignancies: In patients treated with Docetaxel Injection-containing regimens, monitor for delayed AML, MDS, NHL, and renal cancer., Cutaneous reactions: Reactions including erythema of the extremities with edema followed by desquamation may occur. Severe cutaneous adverse reactions have been reported. Severe skin toxicity may require dose adjustment or permanent treatment discontinuation., Neurologic reactions: Reactions including paresthesia, dysesthesia, and pain may occur.
Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.
The most serious adverse reactions from docetaxel are: Toxic Deaths, Hepatic Impairment, Hematologic Effects, Enterocolitis and Neutropenic Colitis, Hypersensitivity Reactions, Fluid Retention, Second Primary Malignancies, Cutaneous Reactions, Neurologic Reactions, Eye Disorders, Asthenia, Alcohol Content The most common adverse reactions across all docetaxel indications are infections, neutropenia, anemia, febrile…
Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.
124 products from 50 makers in the NepalDoc medicine catalog use this generic:
| Brand | Composition | Maker | Pack |
|---|---|---|---|
| C-Celtere 20mg/0.5ml Injection | Docetaxel (20mg/0.5ml) | Celon Lab | |
| C-Celtere 80MG/2ML Injection | Docetaxel (80MG/2ML) | Celon Lab | |
| Daxotel 120mg Injection | Docetaxel (120mg) | Fresenius Kabi pharmaceuticals | |
| Daxotel 20mg Injection | Docetaxel (20mg) | Fresenius Kabi pharmaceuticals | |
| Docetere 120 120mg Injection | Docetaxel (120mg) | Dr. Reddy's Laboratories. | |
| Docetere 20 20mg Injection | Docetaxel (20mg) | Dr. Reddy's Laboratories. | |
| Docetere 80 80mg Injection | Docetaxel (80mg) | Dr. Reddy's Laboratories. | |
| Taxotere 20 20mg Injection | Docetaxel (20mg) | Aventis Pharma Limited. | |
| Taxotere 80 80mg Injection | Docetaxel (80mg) | Aventis Pharma Limited. | |
| Acodocet 120mg Injection | Docetaxel (120mg) | Accord Pharmaceuticals | vial of 1 Injection |
| Acodocet 20 Injection | Docetaxel (20mg) | Accord Pharmaceuticals | vial of 1 Injection |
| Adoxi 120mg Injection Combipack | Docetaxel (120mg) | Adley Formulations | vial of 3 ml Injection |
| Adoxi 20mg Injection Combipack | Docetaxel (20mg) | Adley Formulations | vial of 0.5 ml Injection |
| Adoxi 80mg Injection Combipack | Docetaxel (80mg) | Adley Formulations | vial of 2 ml Injection |
| Apidry 20mg Injection | Docetaxel (20mg) | Taj Pharma India Ltd | vial of 0.5 ml Injection |
| Apidry 80mg Injection | Docetaxel (80mg) | Taj Pharma India Ltd | vial of 2 ml Injection |
| Axidoxel 120 Injection | Docetaxel (120mg) | Axiommax Oncology Pvt Ltd | vial of 3 ml Injection |
| Axidoxel 20 Injection | Docetaxel (20mg) | Axiommax Oncology Pvt Ltd | vial of 0.5 ml Injection |
| Benzoxel 20 Injection | Docetaxel (20mg) | Jenome Biophar Pvt Ltd | vial of 1 Injection |
| Benzoxel 80 Injection | Docetaxel (80mg) | Jenome Biophar Pvt Ltd | vial of 1 Injection |
| Celtere 120mg Injection | Docetaxel (120mg) | Celon Laboratories Ltd | vial of 1 Injection |
| Celtere 20mg Injection | Docetaxel (20mg) | Celon Laboratories Ltd | vial of 1 Injection |
| Celtere 80mg Injection | Docetaxel (80mg) | Celon Laboratories Ltd | vial of 1 Injection |
| Cetexel 80mg Injection | Docetaxel (80mg) | Health Biotech Limited | vial of 1 Injection |
| Chemodoc 120mg Injection | Docetaxel (120mg) | Lupin Ltd | vial of 3 ml Injection |
| Chemodoc 20mg Injection | Docetaxel (20mg) | Lupin Ltd | vial of 1 Injection |
| Chemodoc 80mg Injection | Docetaxel (80mg) | Lupin Ltd | vial of 2 ml Injection |
| Chemotere 120mg Injection | Docetaxel (120mg) | Cytogen Pharmaceuticals India Pvt Ltd | vial of 3 ml Injection |
| Chemotere 20mg Injection | Docetaxel (20mg) | Cytogen Pharmaceuticals India Pvt Ltd | vial of 0.5 ml Injection |
| Chemotere 80mg Injection | Docetaxel (80mg) | Cytogen Pharmaceuticals India Pvt Ltd | vial of 2 ml Injection |
Showing 30 of 124 catalog products. Search the full catalog in the app.
Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.
16.2 Storage Store at 20°C to 25°C (68°F to 77°F).. Retain in the original package to protect from light. Freezing does not adversely affect the product. After first use and following multiple needle entries and product withdrawals, Docetaxel Injection multiple-dose vials are stable for up to 28 days when stored between 2°C and 8°C (36°F and 46°F) and protected from light.
Storage information from the U.S. FDA-approved label.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. NLEM listing does not guarantee that a medicine is in stock at any pharmacy.